Results 111 to 120 of about 7,049,835 (311)

A Study on historical-cultural architectural fabric of Bushehr Port an Urban, cultural and sanitary approach

open access: yesIranian South Medical Journal, 2007
Background: Nowadays ancient cultural historic sites are considered as a local cultural asset. The cultural historic fabric of Bushehr port is one of the most unique historical urban sites which is confronting destruction because of speedy urban ...
darioush Ranjbar   +4 more
doaj  

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan   +16 more
wiley   +1 more source

Cell‐cycle‐specific lesion evolution rather than inhibition of double‐strand‐break repair underpins cisplatin radiosensitization

open access: yesMolecular Oncology, EarlyView.
We analyze cisplatin–DNA adducts (CDAs) and double‐strand breaks (DSBs) in a cell‐cycle‐dependent manner. We find that CDAs form similarly across all cell cycle phases. DSBs arise only in S‐phase. CDAs might not directly impair DSB repair, but S‐phase DSB lesions evolve in the presence of CDAs and disrupt repair in G2, also causing radiosensitization ...
Ye Qiu   +10 more
wiley   +1 more source

Response to Commentary “Cultural-Historical Neuropsychology and ADHD” by Prof. Tatiana V. Akhutina

open access: yesКультурно-историческая психология
The present short review contains the authors response to Commentary “Cultural-Historical Neuropsychology and ADHD” by Prof. Tatiana V.
A. Koutsoklenis   +2 more
doaj   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata   +10 more
wiley   +1 more source

UN INTENTO DE SISTEMATIZACIÓN DE LOS PLANTEAMIENTOS ESENCIALES DEL ENFOQUE HISTÓRICO CULTURAL EN SUS INICIOS

open access: yesPsicologia, 2005
This article intends to present trial systematization and the general concepts of Historical Cultural Approach content¿s, considering its beginning. The article presents several reflections about the reasons that allow considering the historical cultural
Guillermo Arias Beatón
doaj  

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Norwegian cultural policy: a civilising mission? [PDF]

open access: yes
This dissertation aims to explore the extent to which what has been termed „the civilising mission‟ has been a central rationale behind Norwegian cultural policy.
Bjørnsen, Egil
core  

An Attempt to the Systematization of Essentials Contents of Historical Cultural Approach

open access: yesPsicologia, 2005
This article intends to present trial systematization and the general concepts of Historical Cultural Approach content’s, considering its beginning. The article presents several reflections about the reasons that allow considering the historical cultural
Guillermo Arias Beatón
doaj  

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy